Oncolytics Biotech Inc. (NASDAQ:ONCY) and KiOR, Inc. (NASDAQ:KIOR) Added to Growing Stock Report's NASDAQ Decliners Watch List.

New York, NY -- (SBWIRE) -- 03/06/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding Oncolytics Biotech Inc. (NASDAQ:ONCY) and KiOR, Inc. (NASDAQ:KIOR)

Oncolytics Biotech Inc. (NASDAQ:ONCY) a biotechnology company that focuses on the development of oncolytic viruses as potential cancers therapeutics closed down in its previous session (-6.09%) on 569,864 shares traded after Oncolytics Biotech completes patient enrollment in U.S. Phase 2 Reolysin study. Oncolytics Biotech Inc. (NASDAQ:ONCY) is currently down (-34.81%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Oncolytics Biotech Inc. (NASDAQ:ONCY)

KiOR, Inc. (NASDAQ:KIOR) a development stage renewable fuels company that focuses on producing cellulosic gasoline and diesel from non-food biomass using its proprietary biomass-to-cellulosic fuel technology platform closed down in its previous session (-4.28%) on 193,443 shares traded. KiOR, Inc. (NASDAQ:KIOR) is currently down (-64.03%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about KiOR, Inc. (NASDAQ:KIOR)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com